
Practice Management

Podcasts
Continuing Medical Education
Advertisement
Advertisement
Trending on Dermatology Times
1
Sanofi Discontinues Development of OX40L Inhibitor Amlitelimab in Atopic Dermatitis
2
SPD 2026: Phase 3 Success for Lebrikizumab in Younger Pediatric AD Patients
3
Tapinarof Cream Shows Consistent Response Across Pediatric AD Age Groups
4
Sunscreen’s New Blind Spot: Fashion Trends, Tanning Myths, and the Rise of Gluteal Melanomas
5



























